87 related articles for article (PubMed ID: 6145450)
1. Asymmetry of abnormal involuntary movements: a prevalence study.
Myslobodsky MS; Holden T; Sandler R
Biol Psychiatry; 1984 Apr; 19(4):623-8. PubMed ID: 6145450
[No Abstract] [Full Text] [Related]
2. The lateralization of tardive dyskinesia.
Wilson RL; Waziri R; Nasrallah HA; McCalley-Whitters M
Biol Psychiatry; 1984 Apr; 19(4):629-35. PubMed ID: 6145451
[No Abstract] [Full Text] [Related]
3. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Dean CE; Kuskowski MA; Caligiuri MP
J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
[TBL] [Abstract][Full Text] [Related]
4. A five year follow-up study of tardive dyskinesia.
Chouinard G; Annable L; Mercier P; Ross-Chouinard A
Psychopharmacol Bull; 1986; 22(1):259-63. PubMed ID: 2873614
[No Abstract] [Full Text] [Related]
5. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
Grimes JD
Can Med Assoc J; 1982 Mar; 126(5):468. PubMed ID: 6121618
[No Abstract] [Full Text] [Related]
6. Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates.
Lohr JB; Lohr MA; Wasli E; Hilliard B; Larson L; Vardiman E; Wade L; Jeste DV
Psychopharmacol Bull; 1987; 23(1):211-4. PubMed ID: 2885888
[No Abstract] [Full Text] [Related]
7. Drug-induced movement disorders.
Gershanik OS
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
[TBL] [Abstract][Full Text] [Related]
8. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
9. Risperidone-induced tardive dyskinesia and parkinsonism.
Gwinn KA; Caviness JN
Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
[No Abstract] [Full Text] [Related]
10. [Buccofacial dyskinesia of iatrogenic origin].
Reynes P; Guichard M; Guiraud P
Rev Odontostomatol (Paris); 1983; 12(6):461-9. PubMed ID: 6142519
[No Abstract] [Full Text] [Related]
11. Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
Sadananda SK; Holla B; Viswanath B; Narasimha A; Sebastian A; Math SB; Chandrashekar CR
J ECT; 2013 Mar; 29(1):e6-7. PubMed ID: 23422531
[No Abstract] [Full Text] [Related]
12. An investigation of the coexistence of abnormal involuntary movements, parkinsonism, and akathisia in chronic psychiatric inpatients.
Kucharski LT; Wagner RL; Friedman JH
Psychopharmacol Bull; 1987; 23(1):215-7. PubMed ID: 3602322
[No Abstract] [Full Text] [Related]
13. Lateralized neuroleptic-induced side effects are associated with asymmetric visual evoked potentials.
Tomer R; Mintz M; Kempler S; Sigal M
Psychiatry Res; 1987 Dec; 22(4):311-8. PubMed ID: 2893405
[TBL] [Abstract][Full Text] [Related]
14. [Parkinsonism during lithium use].
Walrave TR; Bulens C
Tijdschr Psychiatr; 2009; 51(2):123-7. PubMed ID: 19194854
[TBL] [Abstract][Full Text] [Related]
15. [Drug-induced Parkinson syndrome: 10 years of drug vigilance].
Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
Therapie; 1994; 49(5):459-60. PubMed ID: 7855765
[No Abstract] [Full Text] [Related]
16. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
Trosch RM
J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
[No Abstract] [Full Text] [Related]
17. [Neuroleptics and nicotine].
Erdmann R
Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
Akbostanci MC; Atbaşoğlu EC; Balaban H
Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic trial of tiapride in extrapyramidal syndromes caused by neuroleptics].
Zarranz JJ; Caso C; Blanco J
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(6):503-8. PubMed ID: 6110319
[No Abstract] [Full Text] [Related]
20. Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
Taylor JL; Bishop C; Walker PD
Pharmacol Biochem Behav; 2005 Aug; 81(4):887-93. PubMed ID: 16023708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
